- Home
- FRSX vs EVAX Comparison
FRSX vs EVAX Comparison
Compare FRSX & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSX
- EVAX
- Stock Information
- Founded
- FRSX N/A
- EVAX 2008
- Country
- FRSX Israel
- EVAX Denmark
- Employees
- FRSX N/A
- EVAX N/A
- Industry
- FRSX Computer Software: Prepackaged Software
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FRSX Technology
- EVAX Health Care
- Exchange
- FRSX Nasdaq
- EVAX Nasdaq
- Market Cap
- FRSX 13.7M
- EVAX 16.3M
- IPO Year
- FRSX 2017
- EVAX 2021
- Fundamental
- Price
- FRSX $0.69
- EVAX $1.69
- Analyst Decision
- FRSX
- EVAX Strong Buy
- Analyst Count
- FRSX 0
- EVAX 2
- Target Price
- FRSX N/A
- EVAX $10.00
- AVG Volume (30 Days)
- FRSX 192.7K
- EVAX 65.8K
- Earning Date
- FRSX 05-27-2025
- EVAX 05-27-2025
- Dividend Yield
- FRSX N/A
- EVAX N/A
- EPS Growth
- FRSX N/A
- EVAX N/A
- EPS
- FRSX N/A
- EVAX N/A
- Revenue
- FRSX $436,000.00
- EVAX $3,344,000.00
- Revenue This Year
- FRSX N/A
- EVAX $102.45
- Revenue Next Year
- FRSX N/A
- EVAX $200.44
- P/E Ratio
- FRSX N/A
- EVAX N/A
- Revenue Growth
- FRSX N/A
- EVAX 4480.82
- 52 Week Low
- FRSX $0.57
- EVAX $1.61
- 52 Week High
- FRSX $2.63
- EVAX $22.05
- Technical
- Relative Strength Index (RSI)
- FRSX 41.97
- EVAX 36.47
- Support Level
- FRSX $0.61
- EVAX $1.67
- Resistance Level
- FRSX $0.72
- EVAX $1.97
- Average True Range (ATR)
- FRSX 0.04
- EVAX 0.12
- MACD
- FRSX 0.01
- EVAX 0.04
- Stochastic Oscillator
- FRSX 47.00
- EVAX 22.22
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its advanced systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.